Mylan N.V. News (NASDAQ:MYL)

DateTimeSource
Headline
05/23/20179:15AMPRNUSTheravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS
Theravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS Presentations Review Detailed Efficacy and Safety Data from Two Replicate Pivotal Phase 3 Studies; Report Prevalence of COPD Patients with Low Peak Inspiratory Flow Rate in Ongoing 12-Month Phase... More...>>
05/23/20179:15AMPRNUSTheravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS
Theravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS Presentations Review Detailed Efficacy and Safety Data from Two Replicate Pivotal Phase 3 Studies; Report Prevalence of COPD Patients with Low Peak Inspiratory Flow Rate in Ongoing 12-Month Phase... More...>>
05/17/20178:30AMPRNUSTheravance Biopharma and Mylan to Present Additional Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS
Theravance Biopharma and Mylan to Present Additional Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS Presentations Will Include Detailed Efficacy and Safety Data from Two Replicate Pivotal Phase 3 Studies PR Newswire DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, May 17, 2017 DUBLIN and HERTFORDSHIRE... More...>>
05/16/20174:38PMPRNUSMylan to Present at UBS Global Healthcare Conference
Mylan to Present at UBS Global Healthcare Conference PR Newswire HERTFORDSHIRE, England and PITTSBURGH, May 16, 2017 HERTFORDSHIRE, England and PITTSBURGH, May 16, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the company will present at the UBS Global Healthcare Conference on Monday, May 22... More...>>
05/16/201710:15AMPRNUSMylan Honors National Women's Health Week to Empower Women to Take Control of Their Health
Mylan Honors National Women's Health Week to Empower Women to Take Control of Their Health PR Newswire HERTFORDSHIRE, England and PITTSBURGH, May 16, 2017 HERTFORDSHIRE, England and PITTSBURGH, May 16, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today joins the U.S. Department of Health and Human Services (HHS... More...>>
05/10/20177:30AMPRNUSMylan Reports First Quarter 2017 Results
Mylan Reports First Quarter 2017 Results First Quarter Total Revenues Increase 24% PR Newswire HERTFORDSHIRE, England and PITTSBURGH, May 10, 2017 HERTFORDSHIRE, England and PITTSBURGH, May 10, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced its financial results for the quarter ended March 31, 2017... More...>>
05/01/20179:00AMPRNUSMylan Nominates Sjoerd Vollebregt for Election to Board of Directors
Mylan Nominates Sjoerd Vollebregt for Election to Board of Directors Directors Douglas Leech, Joseph Maroon and Rodney Piatt to Retire from Board PR Newswire HERTFORDSHIRE, England and PITTSBURGH, May 1, 2017 HERTFORDSHIRE, England and PITTSBURGH, May 1, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced... More...>>
04/27/20174:45PMPRNUSMylan to Report First Quarter 2017 Financial Results on May 10, 2017
Mylan to Report First Quarter 2017 Financial Results on May 10, 2017 PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, April 27, 2017 HERTFORDSHIRE, England, and PITTSBURGH, April 27, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that it will host a conference call and live webcast, on Wednesday... More...>>
04/20/20171:39PMPRNUSMylan Launches Generic Trilafon Tablets
Mylan Launches Generic Trilafon Tablets PR Newswire HERTFORDSHIRE, England and PITTSBURGH, April 20, 2017 HERTFORDSHIRE, England and PITTSBURGH, April 20, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL), today announced the U.S. launch of Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg, a generic version of the... More...>>
03/31/20175:11PMPRNUSMylan Provides Update on Meridian Medical Technologies', a Pfizer Company, Expanded Voluntary Worldwide Recall of EpiPen® Au...
Mylan Provides Update on Meridian Medical Technologies', a Pfizer Company, Expanded Voluntary Worldwide Recall of EpiPen® Auto-Injector PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 31, 2017 HERTFORDSHIRE, England and PITTSBURGH, March 31, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced... More...>>
03/29/20174:30PMPRNUSMylan Completes Acquisition of Cold-EEZE® Brand
Mylan Completes Acquisition of Cold-EEZE® Brand PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 29, 2017 HERTFORDSHIRE, England and PITTSBURGH, March 29, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL), today announced the successful acquisition of the global rights to the Cold-EEZE® brand cold remedy line... More...>>
03/29/20171:16PMPRNUSMylan Comments on Generic Advair Diskus® Abbreviated New Drug Application
Mylan Comments on Generic Advair Diskus® Abbreviated New Drug Application PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 29, 2017 HERTFORDSHIRE, England and PITTSBURGH, March 29, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today commented on the status of its abbreviated new drug application (ANDA... More...>>
03/28/20179:00AMPRNUSMylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer
Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 28, 2017 HERTFORDSHIRE, England and PITTSBURGH, March 28, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the appointment of Daniel M. Gallagher as chief legal officer... More...>>
03/20/20171:14PMPRNUSMylan Receives Tentative Approval for "TLE400" Under PEPFAR
Mylan Receives Tentative Approval for "TLE400" Under PEPFAR - TLE400 is a fixed-combination containing Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 400 mg/300 mg/300 mg - PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 20, 2017 HERTFORDSHIRE, England and PITTSBURGH, March 20, 2017... More...>>
03/13/20172:21PMPRNUSMylan Launches Generic Aromasin® Tablets
Mylan Launches Generic Aromasin® Tablets PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 13, 2017 HERTFORDSHIRE, England and PITTSBURGH, March 13, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL), today announced the U.S. launch of Exemestane Tablets, 25 mg, a generic version of the reference listed drug... More...>>
03/13/20178:00AMPRNUSMylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin®
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin® PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 13, 2017 HERTFORDSHIRE, England and PITTSBURGH, March 13, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that Mylan has agreed to the terms of a... More...>>
03/10/201711:00AMPRNUSMylan to Present at Barclays Global Healthcare Conference
Mylan to Present at Barclays Global Healthcare Conference PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 10, 2017 HERTFORDSHIRE, England and PITTSBURGH, March 10, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the company will present at the Barclays Global Healthcare Conference on... More...>>
03/10/20177:30AMPRNUSMylan Launches Generic Pristiq® Tablets
Mylan Launches Generic Pristiq® Tablets PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 10, 2017 HERTFORDSHIRE, England and PITTSBURGH, March 10, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL), today announced the U.S. launch of Desvenlafaxine Extended-release Tablets, 50 mg and 100 mg, a generic version... More...>>
03/01/20179:46AMDJNHot Stocks to Watch in the U.S. and Canada
Among the companies with shares expected to trade actively in Wednesday's session are Best Buy Co. (BBY), Weight Watchers International Inc. (WTW), and Lowe's Cos. (LOW). Best Buy posted a surprise decline in revenue in the final quarter of the year as it struggled to make certain products available to customers... More...>>
03/01/20177:45AMPRNUSMylan Reports Fourth Quarter and Full Year 2016 Results and Provides 2017 Guidance
Mylan Reports Fourth Quarter and Full Year 2016 Results and Provides 2017 Guidance Fourth Quarter Total Revenues Increase 31% and Full Year 2016 Total Revenues Increase 18% PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 1, 2017 HERTFORDSHIRE, England and PITTSBURGH, March 1, 2017 /PRNewswire/ -- Mylan N.V... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V:us D:20170529 18:57:32